Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (19 quarters reported)
— in Q4 2018 → — now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| CT Confidential Treatment Requested | NaN% | Unchanged | 0 | — |
| CT Confidential Treatment Requested | NaN% | Unchanged | 0 | — |
| CT Confidential Treatment Requested | NaN% | Unchanged | 0 | — |
| CT Confidential Treatment Requested | NaN% | Unchanged | 0 | — |
| CT Confidential Treatment Requested | NaN% | Unchanged | 0 | — |
| CT Confidential Treatment Requested | NaN% | Unchanged | 0 | — |
| CT Confidential Treatment Requested | NaN% | Unchanged | 0 | — |
| CT Confidential Treatment Requested | NaN% | Unchanged | 0 | — |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 11, 2026
No position changes this quarter.
quarter ended March 31, 2026 · filed May 12, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| CT Confidential Treatment Requested | Exited | +0 | — | — |
| CT Confidential Treatment Requested | New | +0 | — | — |
| CT Confidential Treatment Requested | New | +0 | — | — |
| CT Confidential Treatment Requested | New | +0 | — | — |
| CT Confidential Treatment Requested | New | +0 | — | — |
| CT Confidential Treatment Requested | New | +0 | — | — |
| CT Confidential Treatment Requested | New | +0 | — | — |
| CT Confidential Treatment Requested | New | +0 | — | — |
| CT Confidential Treatment Requested | New | +0 | — | — |
quarter ended December 31, 2025 · filed February 09, 2026
No position changes this quarter.
quarter ended September 30, 2025 · filed November 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| CT Confidential Treatment Requested | New | +0 | — | — |
| CT Confidential Treatment Requested | Exited | +0 | — | — |
| CT Confidential Treatment Requested | Exited | +0 | — | — |
| CT Confidential Treatment Requested | Exited | +0 | — | — |
| CT Confidential Treatment Requested | Exited | +0 | — | — |
| CT Confidential Treatment Requested | Exited | +0 | — | — |
| CT Confidential Treatment Requested | Exited | +0 | — | — |
quarter ended June 30, 2022 · filed August 11, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| CT Confidential Treatment Requested | New | +0 | — | — |
quarter ended March 31, 2022 · filed May 11, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| CT Confidential Treatment Requested | New | +0 | — | — |
quarter ended December 31, 2021 · filed March 15, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| CT Confidential Treatment Requested | Exited | +0 | — | — |
| CT Confidential Treatment Requested | New | +0 | — | — |
| CT Confidential Treatment Requested | Exited | +0 | — | — |
| CT Confidential Treatment Requested | New | +0 | — | — |
quarter ended September 30, 2021 · filed March 15, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| CT Confidential Treatment Requested | Exited | +0 | — | — |
| CT Confidential Treatment Requested | Exited | +0 | — | — |
Loading...
